Stemline Therapeutics, Inc.
Country
USA
Краткое название
Stemline Therapeutics, Inc.
Headquarters
750 Lexington Avenue 6th Floor New York, NY 10022 United States
Members of the board
Ivan Bergstein,
Stephen P. Hall,
Kenneth Hoberman,
Thomas P. Cirrito,
Eric K. Rowinsky,
Ivan Bergstein,
J. Kevin Buchi,
Kenneth J. Zuerblis,
Eric L. Dobmeier,
Ron Bentsur
Categories medicine
Oncology
Stage of the project
Production
Disease
Blood cancer, Thyroid and vascular gland cancer, Virilia cancer, Muliebria cancer, Breast cancer, Lung cancer, Intestine cancer, Gastric cancer
Ticker
STML
Current owners
Ivan Bergstein,
J. Buchi,
Kenneth Zuerblis,
Eric Dobmeier,
Ron Bentsur,
Hagop Kantarjian,
David Reardon,
Patrick Wen,
Owen O'Connor
Assets
215.4700
Technology
Cell Technologies, Pharmaceuticals, Chemistry